Zhejiang Ausun Pharmaceutical Co., Ltd. (SHA:603229)
China
· Delayed Price · Currency is CNY 9.49
+0.18 (1.93%)
Mar 10, 2026, 11:29 AM CST
SHA:603229 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 7,711 | 8,295 | 7,834 | 9,564 | 10,451 | 8,765 | Upgrade
|
| Market Cap Growth | 3.20% | 5.87% | -18.09% | -8.49% | 19.25% | 170.38% | Upgrade
|
| Enterprise Value | 6,953 | 7,572 | 7,115 | 9,183 | 9,848 | 8,455 | Upgrade
|
| Last Close Price | 9.31 | 9.88 | 9.22 | 11.80 | 12.88 | 10.78 | Upgrade
|
| PE Ratio | 42.05 | 40.11 | 30.86 | 40.64 | 71.62 | 100.93 | Upgrade
|
| Forward PE | 35.13 | 16.29 | 22.58 | 34.87 | 54.34 | 11.21 | Upgrade
|
| PS Ratio | 10.27 | 10.43 | 9.59 | 12.51 | 18.35 | 21.42 | Upgrade
|
| PB Ratio | 3.29 | 3.65 | 3.66 | 6.55 | 8.33 | 7.78 | Upgrade
|
| P/TBV Ratio | 3.51 | 3.92 | 3.94 | 7.36 | 9.58 | 8.35 | Upgrade
|
| P/FCF Ratio | 53.63 | 124.50 | 134.20 | - | - | 192.56 | Upgrade
|
| P/OCF Ratio | 31.91 | 46.62 | 35.32 | 79.33 | 60.10 | 63.30 | Upgrade
|
| EV/Sales Ratio | 9.26 | 9.52 | 8.71 | 12.01 | 17.29 | 20.66 | Upgrade
|
| EV/EBITDA Ratio | 31.41 | 30.50 | 24.96 | 38.32 | 54.04 | 62.95 | Upgrade
|
| EV/EBIT Ratio | 49.18 | 40.78 | 29.10 | 44.75 | 64.70 | 77.65 | Upgrade
|
| EV/FCF Ratio | 48.35 | 113.66 | 121.89 | - | - | 185.75 | Upgrade
|
| Debt / Equity Ratio | 0.16 | 0.12 | 0.14 | 0.17 | 0.09 | 0.04 | Upgrade
|
| Debt / EBITDA Ratio | 1.70 | 1.09 | 1.06 | 1.01 | 0.60 | 0.31 | Upgrade
|
| Debt / FCF Ratio | 2.62 | 4.09 | 5.19 | - | - | 0.90 | Upgrade
|
| Net Debt / Equity Ratio | -0.32 | -0.36 | -0.38 | -0.25 | -0.45 | -0.62 | Upgrade
|
| Net Debt / EBITDA Ratio | -3.44 | -3.33 | -2.88 | -1.55 | -3.10 | -5.20 | Upgrade
|
| Net Debt / FCF Ratio | -5.28 | -12.40 | -14.06 | 2.45 | 4.12 | -15.34 | Upgrade
|
| Asset Turnover | 0.25 | 0.27 | 0.31 | 0.37 | 0.35 | 0.36 | Upgrade
|
| Inventory Turnover | 0.92 | 0.98 | 1.09 | 1.32 | 1.21 | 0.97 | Upgrade
|
| Quick Ratio | 2.13 | 1.92 | 1.63 | 1.01 | 1.40 | 3.22 | Upgrade
|
| Current Ratio | 2.84 | 2.53 | 2.17 | 1.53 | 1.92 | 4.02 | Upgrade
|
| Return on Equity (ROE) | 7.96% | 9.37% | 14.09% | 17.33% | 12.25% | 9.80% | Upgrade
|
| Return on Assets (ROA) | 2.91% | 3.91% | 5.80% | 6.17% | 5.91% | 6.00% | Upgrade
|
| Return on Invested Capital (ROIC) | 7.71% | 11.56% | 17.71% | 21.20% | 24.91% | 25.49% | Upgrade
|
| Return on Capital Employed (ROCE) | 5.80% | 8.00% | 11.20% | 13.10% | 11.60% | 9.60% | Upgrade
|
| Earnings Yield | 2.40% | 2.49% | 3.24% | 2.46% | 1.40% | 0.99% | Upgrade
|
| FCF Yield | 1.86% | 0.80% | 0.74% | -1.58% | -1.31% | 0.52% | Upgrade
|
| Dividend Yield | 1.06% | 1.01% | 1.00% | 0.48% | 0.29% | 0.21% | Upgrade
|
| Payout Ratio | 48.89% | 40.73% | 22.63% | 16.00% | 13.69% | 15.43% | Upgrade
|
| Buyback Yield / Dilution | -3.53% | -0.99% | -1.92% | -1.16% | -6.67% | -0.25% | Upgrade
|
| Total Shareholder Return | -2.47% | 0.02% | -0.92% | -0.68% | -6.38% | -0.03% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.